Effect Of Phalatrikadi Churna Along With Dietery Modification And Musta Churna In The Patients Having Medodushti (Dyslipidemia)

A Comparative Study To Evaluate The Efficacy Of Phalatrikadi Churna Along With Dietery Modification And Musta Churna In The Management Of Medodushti (Dyslipidemia) A Randomized Controlled Open Label Clinical Trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064569

Enrollment

Registered

2024-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients Between The Age Group Of 21-60 Years Of Either Sex. 2)BMI Greater Than 25 Kg Per M2 3)Willing And Able To Participate In The Study For 1month. 4) Patients Having Abnormal Lipid Profile Eg T.Cholesterol Greater Than 200 And T.Cho/HDL Greater Than 4.5. 5)Patients With Strictly Controlled Diabetes Mellitus (Hba1c Less Than Or Equal To 6.5 Percent). 6)Patient With Pratyatma Lakshan Of Medodushti.

Exclusion criteria

Exclusion criteria: 1)Patients With Poorly Controlled Diabetes Mellitus (Hba1c Greater Than 6.5Percent) And Hypertension (BP Greater Than 160 By 100 Mm Hg. 2)Pregnant Or Lactating Woman. 3)BMI Less Than 40kg Per M2 4)Patients With Genetic Syndromes, Severe Cardiovascular Disease Or Any Other Life-Threatening Condition. 5)History Of Hypersensitivity To Any Of The Trial Drugs Or Their Ingredients. 6)Patients Having Systemic Illness Which Will Interfere With The Course Of Procedure. 7)Patients Who Are Already Enrolled In Other Study.

Design outcomes

Primary

Measure	Time frame
1)Significant Favourable Change In Level Of Dyslipidemia Index 2)Improvement In The Signs And Symptoms Of Medoroga. Timepoint: Bsseline After 4Weeks After 8Weeks	—

Secondary

Measure	Time frame
To Improve The Quality Of Life Sf 36Timepoint: Bsseline After 4Weeks After 8Weeks	—

Countries

India

Contacts

Public ContactDr Anjali Kaushik

All India Institute Of Ayurveda

drrky68@gmail.com9412148437

Outcome results